Royalty Pharma Plc (RPRX)
48.57
+0.08
(+0.16%)
USD |
NASDAQ |
Apr 02, 16:00
48.57
0.00 (0.00%)
Pre-Market: 08:46
Royalty Pharma EPS Diluted (Quarterly) : 0.4992 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Zymeworks, Inc. | -0.547 |
| Johnson & Johnson | 2.098 |
| Biogen, Inc. | -0.3333 |
| Revolution Medicines, Inc. | -1.855 |
| Cytokinetics, Inc. | -1.495 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 356.00M |
| Revenue (Quarterly) | 622.00M |
| Total Expenses (Quarterly) | 408.00M |
| Enterprise Value | 32.38B |
| Gross Profit Margin (Quarterly) | 99.81% |
| Profit Margin (Quarterly) | 57.23% |
| Earnings Yield | 3.67% |
| Operating Earnings Yield | 6.03% |
| Normalized Earnings Yield | 3.553 |